Regulation of human papillomavirus transcription by the differentiation-dependent epithelial factor Epoc-1/skn-1a

Journal of Virology

Volumn 70, Issue 1, 1996, Pages 10-16

  Yukawa, Kazunori ^a,c   Butz, Karin ^b   Yasui, Teruhito ^a   Kikutani, Hitoshi ^a   Hoppe Seyler, Felix ^b  

^a OSAKA UNIVERSITY   (Japan)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BASAL CELL; CELL DIFFERENTIATION; EPITHELIUM CELL; GENE ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION; WART VIRUS;

BASE SEQUENCE; CELL DIFFERENTIATION; CELL LINE; DNA, VIRAL; DNA-BINDING PROTEINS; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, VIRAL; HELA CELLS; HUMAN; MOLECULAR SEQUENCE DATA; MUTATION; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS, HUMAN; PROMOTER REGIONS (GENETICS); SUPPORT, NON-U.S. GOV'T; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0029655563     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.1.10-16.1996     Document Type: Article

References (43)

1. Andersen, B., M. D. Schonemann, S. E. Flynn, R. V. Pearse II, H. Singh, and M. G. Rosenfeld. 1993. Skn-1a and skn-li: two functionally distinct Oct-2-related factors expressed in the epidermis. Science 260:78-82
2. Apt, D., T. Chong, Y. Liu, and H. U. Bernard. 1993. Nuclear factor I and epithelial cell-specific transcription of human papillomavirus type 16. J. Virol. 67:4455-4463.
3. Bartsch, D., B. Boye, C. Baust, H. zur Hausen, and E. Schwarz. 1992. Retinoic acid-mediated repression of human papillomaviius 18 transcription and different ligand regulation of the retinoic acid receptor beta gene in non-tumorigenic and tumorigenic HeLa hybrid cells. EMBO J 11:2283-2291.
4. Banknecht, T., P. Angel, H. D. Royer, and H. zur Hausen. 1992. Identification of a negative regulatory domain in the human papulomavirus type 18 promoter: interaction with the transcriptional represser YY1. EMBO J. 11: 4607-4617.
5. Boukamp, P., R. T. Petrussevska, D. Breitkreutz, J. Hornung, A. Markham, and N. Fusenig. 1988. Normal keratmization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol. 106:761-771.
6. Butz, K., and F. Hoppe-Seyler. 1993. Transcriptional control of human papillomavirus (HPV) oncogene expression composition of the HPV type 18 upstream regulatory region J Virol. 67:6476-6486.
7. Butz, K., L. Shahabeddin, C. Geisen, D. Spitkovsky, A. Ullmann, and F. Hoppe-Seyler. 1995. Functional p53 protein in human papillomavirus-positive cancer cells. Oncogene 10:927-936.
8. Chan, W., G. Klock, and H. U. Bernard. 1989 Progesterone and glucocorticoid response elements occur in the long control regions of several human papillomaviruses involved in anogenital neoplasia. J. Virol. 63:3261-3269.
9. Chen, C., and H. Okayama. 1987 High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7:2745-2752.
10. Chow, L. T., and T. R. Broker. 1994. Papillomavirus DNA replication. Intervirology 37:150-158
11. Cole, S. T., and O. Danos. 1987. Nucleotide sequence and comparative analysis of the human papillomavinis type 18 genome. J. Mol. Biol. 193:599-608.
12. dePamphilis, M. L. 1988. Transcriptional elements as components of eukaryotic origins of DNA replication. Cell 52:635-638.
13. Durst, M., D. Glitz, A. Schneider, and H. zur Hausen. 1992 Human papillomavirus type 16 (HPV16) gene expression and DNA replication in cervical neoplasia. analysis by in situ hybridisation. Virology 189:132-140.
14. Garcia-Carranca, A., F. Thierry, and M. Yaniv. 1988. Interplay of viral and cellular proteins along the long control region of human papillomavirus type 18. J Virol. 62:4321-4330.
15. Gius, D., S. Grossmann, M. A. Bedell, and L. A. Laimins. 1988. Inducible and constitutive enhancer domains in the noncoding region of human papillomavirus type 18. J. Virol 62:665-672
16. Gloss, B., M. Yeo-Gloss, M. Meisterernst, L. Rogge, E. L. Winnacker, and H. U. Bernard. 1989. Clusters of nuclear factor I binding sites identify enhancers of several papillomaviruses but alone are not sufficient for enhancer function. Nucleic Acids Res 9:3519-3533
17. Herr, W., R. A. Sturm, R. G. Clerc, L. M. Corcoran, U. Baltimore, P. A. Sharp, H. A. Ingraham, M. G. Rosenfeld, M. Finney, G. Ruvkun, and H. R. Horvitz. 1988. The POU domain: a large conserved region in the mammalian pit-1, oct-1, oct-2, and Caenorhabditis elegans unc-86 gene products. Genes Dev. 2:1513-1516.
18. Hoppe-Seyler, F., and K. Butz. 1992. Activation of human papillomavirus type 18 E6/E7 oncogene expression by transcription factor Spl. Nucleic Acids Res. 20:6701-6706.
19. Hoppe-Seyler, F., and K. Butz. 1993. A novel cis-regulatory element maps to the 5′-portion of the human papillomavirus type 18 upstream regulatory region and is functionally dependent on a sequence-aberrant Sp1 binding site. J. Gen. Virol. 74:281-286.
20. Hoppe-Seyler, F., and K. Butt. 1994. Cellular control of human papillomavirus oncogene transcription. Mol. Carcinog. 10:134-141.
21. Hoppe-Seyler, F., K. Butz, and H. zur Hausen. 1991. Repression of the human papillomavirus type 18 enhancer by the cellular transcription factor Oct-1. J. Vnol. 65:5613-5618.
22. Ishiji, T., M. J. Lace, M. S. Parkkinen, R. Anderson, T. Haugen, T. Cripe, J.-H. Xiao, I. Davidson, P. Chambon, and L. Turek. 1992. Transcriptional enhancer factor (TEF)-1 and its cell-specific co-activator activate human papillomavirus-16 E6 and E7 oncogene transcription in keratinocytes and cervical carcinoma cells. EMBO J. 11:2271-2281
23. Jones, N. C., P. J. W. Rigby, and E. B. Ziff. 1988. Trans-acting protein factors and the regulation of eukaryotic transcription: lessons from studies on DNA tumor viruses. Genes Dev. 2:267-281.
24. Mack, D. H., and L. A. Laimins. 1991 A keratinocyte-specific transcription factor, KRF-1. interacts with AP-1 to activate expression of human papillomavirus type 18 in squamous epithelial cells. Proc Natl. Acad. Sci. USA 88: 9102-9106
25. Maxam, A. M., and W. Gilbert. 1977. A new method of sequencing DNA. Proc Natl. Acad. Sci. USA 74:560-564
26. Mizushima, S., and S. Nagata. 1990. pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res. 18:5322
27. Morris, P., C. Dent, C. Ring, and D. Latchman. 1993. The octamer binding site in the HPV16 regulatory region produces opposite effects on gene expression in cervical and non-cervical cells. Nucleic Acids Res. 21:1019-1023.
28. O'Connor, M., and H. U. Bernard. 1995, Oct-1 activates the epithelial-specific enhancer of human papillomavirus type 16 via a synergistic interaction with NFI at a conserved composite regulatory element. Virology 207: 77-88.
29. Offord, E. A., and P. Beard. 1990. A member of the activator protein 1 family found in keratmocytes but not in fibroblasts required for transcription from a human papillomavirus type 18 promoter. J. Virol. 64:4792-4798.
30. Rosenfeld, M. G. 1991. POU-domain transcription factors pou-er-ful developmental regulators Genes Dev. 5:897-907
31. Shah, K. V., and P. M. Howley. 1990 Papillomaviruses, p. 1651-1676. In B. N. Fields and D. M. Knipe (ed.), Virology. Raven Press, New York.
32. Stoler, M. H., C. R. Rhodes, A. Whitbeck, S. M. Wolinski, L. T. Chow, and T. R. Broker. 1992. Human papillomavirus type 16 and 18 gene expression in cervical neoplasias. Hum. Pathol. 23:117-128
33. Tanaka, M., and W. Herr. 1990. Differential transcriptional activation by Oct-1 and Oct-2: interdependent activation domains induce Oct-1 phosphorylation. Cell 60:375-386.
34. Thierry, F., A. Garcia-Carranca, and M. Yaniv. 1987 Elements that control the transcription of genital papillomavirus type 18. Cancer Cells 5:23-32.
35. Thierry, F., J. M. Heard, K. Dartmann, and M. Yaniv. 1987. Characterization of a transcriptional promoter of human papillomavirus type 18 and modulation of its expression by simian virus 40 and adcnovirus early antigens. J. Virol. 61:134-142.
36. Thierry, F., G. Spyrou, M. Yaniv, and P. M. Howley. 1992. Two AP1 sites binding JunB are essential for human papillomavirus type 18 transcription in keratinocytes. J Virol. 66:3740-3748.
37. Turek, L. P. 1994. The structure, function, and regulation of papillomaviral genes in infection and cervical cancer. Adv. Virus Res. 44:305-356.
38. von Knebel Doeberitz, M. 1992. Papillomaviruses in human disease. Part II. Molecular biology and immunology of papillomavirus infections and carcinogenesis. Eur. J. Med. 1:485-491.
39. Wilkinson, D. G., S. Bhatt, R. P. Ryseck, and R. Bravo. 1989. Tissue specific expression of c-jun and junB during organogenesis in the mouse. Development 106:465-471.
40. Yukawa, K., and H. Kikutaui. Unpublished data.
41. Yukawa, K., T. Yasui, A. Yamamoto, H. Shiku, T. Kishimoto, and H. Kikutani. 1993. Epoc-1: a POU-domain gene expressed in murine epidermal basal cells and thymic stromal cells. Gene 133:163-169.
42. zur Hausen, H. 1986. Intracellular surveillance of persisting viral infections. Human genital cancer results from deficient cellular control of papillomavirus gene expression. Lancet ii:489-491.
43. zur Hausen, H. 1994. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Curr. Top Microbiol. Immunol 186:131-156